Lupin Limited secures major victory: A perfect FDA score for its Gujarat plant
Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). ... Read More
Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief Executive Officer of its newly established subsidiary, ... Read More
Lupin Limited expands global specialty portfolio with strategic acquisitions
Global pharmaceutical leader Lupin Limited (Lupin) has announced the completion of a strategic acquisition through its European hub, Lupin Atlantis Holdings SA. The company has ... Read More
Lupin Limited appoints Christoph Funke as Chief Technical Operations Officer to spearhead global pharmaceutical operations
Lupin Limited, a global leader in the pharmaceutical industry, announced today the strategic appointment of Christoph Funke to the newly created role of Chief Technical ... Read More
Lupin Limited secures FDA approval for generic Bromfenac Ophthalmic Solution
In a significant development for the global pharmaceutical industry, Lupin Limited (Lupin) has announced its latest achievement: receiving approval from the United States Food and ... Read More
Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More
Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics
Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by acquiring Symbiomix Therapeutics. The acquisition, valued at ... Read More